Conference Coverage

Revascularization in paraplegics best performed with PCI


 

AT THE 2018 CRT MEETING

– When paraplegics and quadriplegics have an acute MI and are candidates for revascularization, they should be treated preferentially with a percutaneous coronary intervention, according to data presented at the 2018 Cardiovascular Research Technologies meeting.

When compared 30 days after revascularization, the rates of major adverse cardiovascular events (MACE) following coronary artery bypass grafting (CABG) were 22% in the group with paraplegia or quadriplegia versus only 3.5% in those without loss of limb function. For percutaneous coronary intervention (PCI), the rates were 6% versus 2%, respectively, reported Xuming Dai, MD, PhD, an interventional cardiologist and assistant professor at the University of North Carolina at Chapel Hill.

Dr. Xuming Dai

Dr. Xuming Dai

A study of revascularization outcomes in patients with paraplegia or quadriplegia was undertaken after Dr. Dai was faced with two such patients, of whom one was ultimately referred for CABG. Concerned at the time about the suitability of CABG for patients with the potential for risk factors different from ambulatory patients, Dr. Dai consulted the literature.

“There are no guidelines, no studies. I could not even find a case report,” Dr. Dai recounted.

Pages

Recommended Reading

VIDEO: No short-term link found between PPIs, myocardial infarction
MDedge Family Medicine
Viremic suppression linked to decreased MACE rate in patients with HCV-cirrhosis
MDedge Family Medicine
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Family Medicine
Abruptio placenta brings increased cardiovascular risk – and soon
MDedge Family Medicine
Sex-triggered sudden cardiac arrest extremely rare
MDedge Family Medicine
200 cardiovascular drugs now in development
MDedge Family Medicine
Young diabetics are at sevenfold increased risk of sudden cardiac death
MDedge Family Medicine
ACC Late-Breaking Clinical Trial sessions preview for day 1
MDedge Family Medicine
ACC Day 2: Late-Breaking Clinical Trial highlights
MDedge Family Medicine
Heart attacks soar in young IBD patients
MDedge Family Medicine